MedChemWatch
Monthly Newsletter December 2015

The EFMC wishes you a successful New Year!

2016 will be a busy and exciting year for the EFMC...

Our main events will again take place in 2016: the XXIV EFMC International Symposium on Medicinal Chemistry (August 28 – September 1, 2016 – Manchester, United Kingdom) organised by the Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry.

The EFMC will also continue the tradition of the Short Courses in 2016 and is pleased to announce the following course: 12th EFMC Short Course on Medicinal Chemistry Modulation of Enzymes; Epigenetics and Beyond, which will take place in Oegstgeest (near Leiden), The Netherlands - April 24-27, 2016

News from the Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (UK)

BMCS invites registrations and poster submissions for the 3rd New Perspectives in DMPK: The Impact of Drug Design and announces:

  • the 2015 Malcom Campbell Memorial Prize
  • the Royal Society of Chemistry, Biological and Medicinal Chemistry Sector ‘Lifetime Achievement Award in Medicinal Chemistry

ARE YOU INTO DMPK? CALL FOR POSTERS AND REGISTRATION NOW OPEN: 3RD NEW PERSPECTIVES IN DMPK: THE IMPACT OF DRUG DESIGN. 8TH AND 9TH FEBRUARY 2016 AT THE ROYAL SOCIETY OF CHEMISTRY, BURLINGTON HOUSE, LONDON

Closing date for poster submission is 15th January.

This meeting will provide a forum for the exchange of ideas between principal members of the DMPK research community. The agenda will include keynote talks from industry leaders, who will frame specific topic discussions with more global views of how DMPK can bring value to the process of informing drug discovery. The emphasis throughout will be on building dialogue between participants who will range from experienced project/laboratory leaders to early-career researchers, via platform presentations, Q&A, poster sessions, and associated social mixer events.

Website: http://www.rsc.org/events/detail/19562/3rd-new-perspectives-in-dmpk-the-impact-of-drug-design


WHAT STAR©’S! 2015 MALCOM CAMPBELL MEMORIAL PRIZE AWARDED TO MILES CONGREVE, FIONA MARSHALL AND MALCOM WEIR, HEPTARES THERAPEUTICS LTD.

The prize was for the seminal contributions to GPCR drug discovery made by Heptares Therapeutics Ltd since the company was founded in 2007.

This work has included building the world-renowned StaR© technology platform for X-ray crystallography of GPCRs and the invention of a number of clinical candidates.

More information is available on http://www.rsc.org/Membership/Networking/InterestGroups/BMCS/Activities/CampbellAward.asp

 

SIR SIMON CAMPBELL AWARDED THE FIRST ‘RSC-BMCS LIFETIME ACHIEVEMENT AWARD’

Sir Simon Campbell was presented with the inaugural Royal Society of Chemistry, Biological and Medicinal Chemistry Sector ‘Lifetime Achievement Award in Medicinal Chemistry at the 18th RSC-SCI Medicinal Chemistry Symposium in Cambridge on Wednesday 16th September 2015 in recognition of his many contributions to the field.

Find out more on http://www.rsc.org/Membership/Networking/InterestGroups/BMCS/ (scroll to bottom of page)

Partnership agreement between Life Science Switzerland (LS2) and the Division of Medicinal Chemistry & Chemical Biology (DMCCB) of the Swiss Chemical Society (SCS)

The coalition Life Sciences Switzerland (LS2) is a non-profit organisation dedicated to advancing biological sciences within the Swiss academic community and to addressing the social, ethical and economic issues raised by the rapid progress of the biomedical and life sciences. Life Science Switzerland (LS2) and the Division of Medicinal Chemistry & Chemical Biology (DMCCB) of the Swiss Chemical Society (SCS) have signed an agreement to establish a collaborative relationship for the progress of Life Science, with focus on Medicinal Chemistry, Chemical Biology and related fields of research in Switzerland.

The main points of the agreement are that

  • both partners will establish regular interactions to explore synergies between their societies, and inform their members about the activities of the other party.
  • the DMCCB will organize a scientific session at the next LS2 annual meeting in Lausanne, while LS2 will organize a session at the SCS Fall Meeting in 2017.
  • in addition, members of both societies are offered regular member registration fees at each other's event, as well as a one-off 10% discount for new dual memberships.
  • finally, LS2 will guest-edit the December 2016 edition of CHIMIA, showcasing its scientific activities to the SCS members.

Both organizations are looking forward to an open and constructive collaboration aiming to develop into a strong partnership, for the benefit of life sciences, medicinal chemistry and chemical biology in Switzerland.

Prof. Gabriele Costantino is the President of the Division of Medicinal Chemistry of the Italian Chemical Society for the 2016-2018 Term

More than 600 members of the Division of Medicinal Chemistry of the Italian Chemical Society have been called to the election of the President and the Executive Committee for the 2016-2018.

The new President is Gabriele Costantino, professor of medicinal chemistry at University of Parma. The new Executive Committee is composed by Cosimo Altomare (University of Bari), Tiziano Bandiera (Italian Institute of Technology, Genova), Federico Corelli (University of Siena), Maurizio DelCanale (Chiesi Farmaceutici, Parma), Roberto Di Santo (University of Rome ‘La Sapienza), Vincenza Andrisano (University of Bologna), Gianluca Sbardella (University of Salerno) and Girolamo Cirrincione (Past President, University of Palermo). Gabriele Costantino, who has served as a Member of the Executive Committee of the EFMC (2010-2015) will be the official representative of Italy at the EFMC Council.

Frontiers in Medicinal Chemistry - Bonn, Germany - March 13-16, 2016

This symposium, jointly organised by the Deutsche Pharmazeutische Gesellschaft (GDCh-DPhG) and the Société de Chimie Thérapeutique (SCT), will focus on current developments, novel approaches and cutting-edge technologies in the field of medicinal chemistry and drug research with sessions on Target Identification & Lead Discovery, Allosteric Modulators & Modulation of Protein-Protein Interactions, Antibacterial Drugs, Structural Biology, and Highlights in Medicinal Chemistry and Technology.

The scientific program will include plenary lectures, short lectures, and poster presentations. Furthermore, oral communications of (post)doctoral junior scientists will be considered. It is the goal of the organizers to make this meeting an event of scientific excellence, attractive to both industrial and academic scientists in Medicinal Chemistry and related fields of research. 

Find out more:

http://www.sct-asso.fr/springmeetingpresentation.html
https://www.gdch.de/veranstaltungen/tagungen/gdch-tagungen-2016/frontiers-in-medicinal-chemistry.html

2016 IUPAC-Richter Prize in Medicinal Chemistry

The 2016 IUPAC-Richter Prize will be presented during the XXIV EFMC International Symposium on Medicinal Chemistry (August 28 - September 1, 2016) in Manchester (UK), where the recipient will also give a plenary lecture on the subject of his/her research.

The prize is to be awarded to an internationally recognized scientist, preferably a medicinal chemist, whose activities or published accounts have made an outstanding contribution to the practice of medicinal chemistry or to an outstanding example of new drug discovery.

Prize USD 10 000

The Prize has been established by a generous gift from the Chemical Works of Gedeon Richter, Plc. (Budapest, Hungary) to acknowledge the key role that medicinal chemistry plays towards improving human health.

Applicants should be received by NOMINATION only, with just one person needing to serve in that capacity, although a total of five (5) individuals should be listed as referees overall. The package must be submitted electronically and should contain a complete resume, a professional autobiography of not more than two pages, and a one-page summary of what the individual considers to be his/her activities, accomplishments and/or publications that have had the most significant impact upon the field of Medicinal Chemistry. The material will be forwarded confidentially to an independent selection committee appointed by the IUPAC Subcommittee on Medicinal Chemistry and Drug Development.

For further information, please contact Professor Janos Fischer, Chariman of the IUPAC Subcommittee on Drug Discovery and Drug Development, by email at j.fisher@richter.hu

Nomination materials should be submitted by 15 February 2016 to IUPAC
Secretariat by email at: secretariat@iupac.org
Telephone: +1 (919) 485 8700
Fax: +1 (919) 485 8706

 

EFMC ORGANISED EVENTS

September 6-7, 2018
Ljubljana, Slovenia
5th EFMC Young Medicinal Chemist Symposium (EFMC-YMCS 2018)

EFMC SPONSORED EVENTS

January 28 - February 1, 2018
St Anton, Austria
1st Alpine Conference on Medicinal and Synthetic Chemistry

JOB PORTAL

Early Stage Researcher in Medicinal Chemistry, University of Basel (UNIBAS), University of Utrecht (UU), PamGene: Department of Pharmaceutical Sciences (UNIBAS), Department of Chemical Biology & Drug Discovery (UU), Basel, Utrecht, 's-Hertogenbosch, Switzerland
Read more


Early Stage Researcher in Medicinal Chemistry, University of Ljubljana (UL), University of Utrecht (UU), PamGene: Faculty of Pharmacy, Chair of Pharmaceutical Chemistry (UL), Department of Chemical Biology & Drug Discovery (UU), Ljubljana, Utrecht, 's-Hertogenbosch, Slovenia
Read more


Early Stage Researcher in Medicinal Chemistry, University of Utrecht (UU), University of Ljubljana (UL), PamGene: Department of Chemical Biology & Drug Discovery (UU), Faculty of Pharmacy, Chair of Pharmaceutical Chemistry (UL), Utrecht, Ljubljana, 's-Hertogenbosch, The Netherlands
Read more


Early Stage Researcher in Medicinal Chemistry, University of Basel (UNIBAS), University of Ljubljana (UL): Department of Pharmaceutical Sciences (UNIBAS), Faculty of Pharmacy, Chair of Pharmaceutical Chemistry (UL), Basel, Ljubljana, Switzerland
Read more


Early Stage Researcher in Medicinal Chemistry, University of Ljubljana (UL), Lund University (ULUND), SARomics, Red Glead: Faculty of Pharmacy, Chair of Pharmaceutical Chemistry (UL), Department of Chemistry (ULUND), Ljubljana, Slovenia
Read more


Early Stage Researcher in Medicinal Chemistry, Università degli Studi di Milano (UMIL), Universiteit Utrecht (UU), PamGene: Chemistry (UMIL), Department of Chemical Biology & Drug Discovery (UU), Milano, Utrecht, 's-Hertogenbosch, Italy
Read more


Early Stage Researcher in Medicinal Chemistry, Università degli Studi di Milano (UMIL), Université Grenoble Alpes (UGA), Centre national de la recherche scientifique (CNRS-Glycopedia): Chemistry (UMIL), CERMAV (UGA), Milano, Gières, Grenoble, Italy
Read more


Early Stage Researcher in Medicinal Chemistry, Université Grenoble Alpes (UGA), Universiteit Utrecht (UU), PamGene: CERMAV (UGA), Department of Chenical Biology & Drug Discovery (UU), Gières, Utrecht, 's-Hertogenbosch, France
Read more


Early Stage Researcher in Medicinal Chemistry, Universiteit Utrecht (UU), Université Grenoble Alpes (UGA), Centre national de la recherche scientifique (CNRS): Department of Chemical Biology & Drug Discovery (UU), CERMAV (UGA), Utrecht, Gières, Grenoble, The Netherlands 
Read more


Early Stage Researcher in Medicinal Chemistry Université Grenoble Alpes (UGA), Università degli Studi di Milano (UMIL), Centre national de la recherche scientifique (CNRS) : CERMAV (UGA), Department of Chemistry (UMIL), Gières, Milano, Grenoble, France
Read more


Research / Senior Scientist Medicinal Chemistry, UCB: Medicinal Chemistry, Braine-L'Alleud, Belgium
Read more


Principal Scientist Medicinal Chemistry, UCB: Medicinal Chemistry, Braine-L'Alleud, Belgium
Read more


Medicinal / Synthetic Organic Chemists, Concept Life Sciences: Drug Discovery, Sandwich, Kent, United Kingdom
Read more

Find us on social media

EFMC Facebook EFMC Twitter EFMC LinkedIn

EFMC